ACCESSNCT06730555
Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
StatusActive, Not Recruiting
PhaseNot applicable
SponsorUniversity of Miami
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 10 words Show 4 more changesShow less
- Enrollment closed, study ongoing
- Final enrollment: 36 participants (planned 40)
- Secondary endpoints: details revised at 1 of 1 entry
- Site details revised
- Minor Enrollment target: 32 to 40
- Site contact updated
- Notable Primary endpoints revised (2)
- Secondary endpoints: details revised at 1 of 1 entry
- Site contact updated
- Notable Eligibility criteria expanded, about 5 wordsv4
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
- Start date changed from estimate of Aug 1, 2025 to Jun 27, 2025
- Secondary endpoints: 3 to 1
- Site details revised
- Study title shortened, about 1 word
- Notable Primary endpoints: 1 to 2
- Site contact updated
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of SSP participants reached
Timeframe: up to 18 months
Adoption
Timeframe: up to 6 months
Secondary (1)
Number of SSP participants reached after the intervention
Arms and interventions
ACCESS GroupExperimental
Participants in this group will receive the ACCESS intervention for up to 18 months
Control GroupActive comparator
Participants in this group will receive a link to the CDC Compendium of Evidence-Based Interventions for up to 18 months.
Behavioral: ACCESS Intervention, Control Group
Sites
1 site in 1 country
- University of MiamiMiami, Florida, United States